LIXTE BIOTECHNOLOGY HOLDINGS, INC. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Lixte Biotechnology Holdings, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Lixte Biotechnology Holdings, Inc. Return On Equity for the quarter ending June 30, 2024 was -113 %, a 15.7% increase year-over-year.
  • Lixte Biotechnology Holdings, Inc. annual Return On Equity for 2023 was -130 %, a 15.8% decline from 2022.
  • Lixte Biotechnology Holdings, Inc. annual Return On Equity for 2022 was -112 %, a 5.63% decline from 2021.
  • Lixte Biotechnology Holdings, Inc. annual Return On Equity for 2021 was -106 %, a 19.8% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -130 -17.7 -15.8% Jan 1, 2023 Dec 31, 2023
2022 -112 -5.97 -5.63% Jan 1, 2022 Dec 31, 2022
2021 -106 +26.1 +19.8% Jan 1, 2021 Dec 31, 2021
2020 -132 -52.8 -66.5% Jan 1, 2020 Dec 31, 2020
2019 -79.4 +92.2 +53.7% Jan 1, 2019 Dec 31, 2019
2018 -172 -23.4 -15.7% Jan 1, 2018 Dec 31, 2018
2017 -148 +117 +44% Jan 1, 2017 Dec 31, 2017
2016 -265 +29.8 +10.1% Jan 1, 2016 Dec 31, 2016
2015 -295 +342 +53.7% Jan 1, 2015 Dec 31, 2015
2014 -636 -447 -236% Jan 1, 2014 Dec 31, 2014
2013 -189 +106 +36% Jan 1, 2013 Dec 31, 2013
2012 -296 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.